作者：
Valerie E,Crolley [1]
;
Husam,Marashi [2]
;
Shabbir,Rawther [3]
;
Bhawna,Sirohi [4]
;
Marina,Parton [5]
;
Janine,Graham [6]
;
Anup,Vinayan [7]
;
Stephanie,Sutherland [8]
;
Anne,Rigg [9]
;
Anshu,Wadhawan [9]
;
Catherine,Harper-Wynne [10]
;
Emma,Spurrell [11]
;
Hannah,Bond [12]
;
Fharat,Raja [13]
;
Judy,King [14]
作者单位：
Royal Free London NHS Foundation Trust, London, UK. valerie.crolley@nhs.net.
[1]
Barts Health NHS Trust, London, UK. valerie.crolley@nhs.net.
[2]
Beatson West of Scotland Cancer Centre, Glasgow, UK.
[3]
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
[4]
Barts Health NHS Trust, London, UK.
[5]
Royal Marsden NHS Foundation Trust, London, UK.
[6]
South Tees NHS Foundation Trust, Middlesbrough, UK.
[7]
Luton & Dunstable NHS Trust, Luton, UK.
[8]
Mount Vernon Cancer Centre, Northwood, UK.
[9]
Guys and St Thomas NHS Foundation Trust, London, UK.
[10]
Velindre University NHS Trust, Cardiff, UK.
[11]
Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK.
[12]
The Whittington Hospital NHS Trust, London, UK.
[13]
Royal Cornwall Hospitals NHS Trust, Truro, UK.
[14]
University College London Hospitals NHS Foundation Trust, London, UK.
[15]
North Middlesex University Hospital NHS Trust, London, UK.
[16]
Royal Free London NHS Foundation Trust, London, UK.
[17]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);女(雌)性(Female);随访研究(Follow-Up Studies);基因表达谱(Gene Expression Profiling);人类(Humans);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);诊疗准则(主题)(Practice Guidelines as Topic);预后(Prognosis);受体, 雌激素(Receptors, Estrogen);受体, 孕酮(Receptors, Progesterone);研究设计(Research Design);回顾性研究(Retrospective Studies)
DOI
10.1007/s10549-020-05578-6
PMID
32170635
发布时间
2020-12-14
换一批
换一批
